How much funding has ALTO NEUROSCIENCE, INC. raised?

ALTO NEUROSCIENCE, INC. has raised $165.0M in total funding, most recently a Growth Equity round.

When was ALTO NEUROSCIENCE, INC. founded?

ALTO NEUROSCIENCE, INC. was founded in 2020.

Where is ALTO NEUROSCIENCE, INC. headquartered?

ALTO NEUROSCIENCE, INC. is headquartered in LOS ALTOS, California, United States.

What industry is ALTO NEUROSCIENCE, INC. in?

ALTO NEUROSCIENCE, INC. operates in Biotech, Healthcare.

How many employees does ALTO NEUROSCIENCE, INC. have?

ALTO NEUROSCIENCE, INC. has 1-10 employees.

ALTO NEUROSCIENCE, INC.

Leading Innovation in Psychiatric Treatment | Alto Neuroscience

LOS ALTOS, United States · Founded 2020 · $165.0M raised

Biotech

Healthcare

Headquarters: LOS ALTOS, California
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: altoneuroscience.com
Total Funding: $165.0M
Last Round: $120.0M Growth EquityMar 2026
Rounds: 2

About

Alto Neuroscience is a clinical-stage biopharmaceutical company redefining psychiatry by leveraging deep neurobiological insights to develop personalized medicines for neuropsychiatric conditions. Using a precision psychiatry platform built on 15 years of neurobiology research, the company targets core brain processes in patients with major depressive disorder, bipolar depression, and schizophrenia.

Summary

ALTO NEUROSCIENCE, INC. is a Biotech company based in LOS ALTOS, United States, founded in 2020. It has raised $165.0M in total across 2 rounds, most recently a $120.0M Growth Equity round in Mar 2026.

LinkedIn X (Twitter)